Optimal management of prostate cancer with lethal biology – state-of-the-art local therapy

por Chapin, Brian F
Publicado 2015

Very-high-risk (VHR) localized prostate cancer: an indication for multimodal therapy

por Sundi, Debasish, Chapin, Brian F.
Publicado 2019

Emerging role of cytoreductive prostatectomy in patients with metastatic disease

por Jaber, Yasmeen, Reichard, Chad A., Chapin, Brian F.
Publicado 2018

Contemporary outcomes following robotic prostatectomy for locally advanced and metastatic prostate cancer

por McCormick, Barrett Z., Chery, Lisly, Chapin, Brian F.
Publicado 2021

Impact of CoVID-19 on resident and fellow education: Current guidance and future opportunities for urologic oncology training programs

por Westerman, Mary E., Tabakin, Alexandra L., Sexton, Wade J., Chapin, Brian F., Singer, Eric A.
Publicado 2021

Increased body mass index is associated with operative difficulty during robot‐assisted radical prostatectomy

por Shapiro, Daniel D., Davis, John W., Williams, Wendell H., Chapin, Brian F., Ward, John F., Pettaway, Curtis A., Gregg, Justin R.
Publicado 2021

Research highlights of the 2020 society of urologic oncology young urologic oncologists’ program

por Klaassen, Zachary, Scarpato, Kristen R., Ristau, Benjamin T., Stratton, Kelly L., Porten, Sima P., Smaldone, Marc C., Chapin, Brian F., Psutka, Sarah P.
Publicado 2021

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)

por Siddiqui, Bilal A, Chapin, Brian F, Jindal, Sonali, Duan, Fei, Basu, Sreyashi, Yadav, Shalini S, Gu, Ai-Di, Espejo, Alexsandra B, Kinder, Michelle, Pettaway, Curtis A, Ward, John F, Tidwell, Rebecca S S, Troncoso, Patricia, Corn, Paul G, Logothetis, Christopher J, Knoblauch, Roland, Hutnick, Natalie, Gottardis, Marco, Drake, Charles G, Sharma, Padmanee, Subudhi, Sumit K
Publicado 2023